All News

Analyst Trilliant Health argues the case for major changes from inside — or new regulations from outside.

Aerin Medical device uses temperature- and impedance-controlled radiofrequency to treat multiple anatomical drivers of chronic rhinitis

How will artificial intelligence reshape the rules of medical malpractice? Northeastern University’s David Simon unpacks the legal, ethical and practical dilemmas now confronting physicians, hospitals and AI developers.

The top news stories in medicine today.

David Simon, J.D., LL.M., Ph.D., looks ahead at how widespread AI adoption may de-skill physicians, trigger early waves of litigation and push courts to create new legal norms for medical technology.

A new educational effort from Ipsen spotlights one of medicine’s most overlooked weak points: the transition from pediatric to adult care.

Sara Gerke discusses her proposal for AI “facts labels,” arguing that transparency in device labeling could help physicians, health systems and regulators share accountability.

David Simon, J.D., LL.M., Ph.D., says AI could cut malpractice claims if it becomes part of the accepted standard of care — but shift liability toward manufacturers in product defect cases.

Bain & Company finds hospitals accelerating investment in primary care and value-based care, even as labor shortages and patient skepticism over AI threaten progress.

State-level scrutiny of private equity in health care intensifies as new laws emerge, shifting focus from federal antitrust enforcement.

David Simon, J.D., LL.M., Ph.D., contrasts the European Union’s proactive approach to AI oversight with the U.S. system’s reliance on courts and the FDA — and argues for a middle path balancing innovation and accountability.

Physicians, medical student collaborate on a primer of problems and solutions.

U.S. medical device manufacturers leverage AI and digital compliance to enhance innovation, safety, and patient-centric designs amid regulatory challenges.

David Simon, J.D., LL.M., Ph.D., explores how public skepticism toward “robot diagnosis” could shape future court decisions, even as confidence in AI’s accuracy grows over time.

Strategies for organizations to navigate CMS's decision to fast-track risk adjustment audits.

With denials cutting deeper into practice revenue, physicians are turning to AI-driven tools to catch errors before submission, automate appeals and reduce administrative burnout.

Paul Merrick, M.D., and Dan Greenleaf of Duly Health and Care join the show to discuss how independent physician groups can stay competitive, lower costs and preserve autonomy amid consolidation across the health care industry.

Sara Gerke explains why jurors may soon see following an AI recommendation as the “reasonable” choice, even when it diverges from traditional medical standards.

David Simon, J.D., LL.M., Ph.D., explains why AI outputs are unlikely to define medical negligence — unless courts first determine that the AI itself represents the standard of care.

Prior authorization remains one of the top pain points in health care, consuming hours of physician and staff time each week and delaying care for countless patients. This Medical Economics FAQ unpacks the most common questions physicians ask about prior authorization, its real costs, and what reforms may be on the horizon.

The top news stories in medicine today.

David Simon, J.D., LL.M., Ph.D., examines the unresolved gray areas between physicians, hospitals and AI manufacturers when errors occur.

Drawing from past device litigation, David Simon, J.D., LL.M., Ph.D., outlines how product liability claims against AI developers and device makers may mirror — and expand upon — traditional malpractice law.

David Simon, J.D., LL.M., Ph.D., discusses how AI could gradually reshape the legal definition of the “standard of care," and what happens when not all physicians or systems have equal access to these tools.

David Simon, J.D., LL.M., Ph.D., explains why the first clues to artificial intelligence malpractice law may come from outside of medicine — including recent verdicts in the autonomous vehicle industry.

Sara Gerke of the University of Illinois explains how artificial intelligence is already challenging malpractice law — and why unclear liability could slow safe adoption.

Fujifilm unveils the ELUXEO 8000 Endoscopic Imaging System, enhancing visualization and precision in gastrointestinal procedures with advanced imaging technology.

“This is about building a powerful bridge between the science that transforms lives and the systems that deliver that transformation,” said Michael J. Hennessy Jr., MJH Life Sciences chairman and CEO, of the BPD Healthcare acquisition.